Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.19 Analyst target: $25.67 Upside: 1072.15%
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.